Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer

被引:182
|
作者
Wheeler, TM
Dillioglugil, O
Kattan, MW
Arakawa, A
Soh, S
Suyama, K
Ohori, M
Scardino, PT
机构
[1] Baylor Coll Med, Dept Pathol, Scott Dept Urol, Houston, TX 77030 USA
[2] Baylor Coll Med, Matsunaga Conte Prostate Canc Res Ctr, Houston, TX 77030 USA
[3] Baylor Coll Med, Informat Technol Program, Houston, TX 77030 USA
[4] Methodist Hosp, Houston, TX 77030 USA
关键词
prostatic neoplasms; prostatectomy; extraprostatic extension; prostatic capsular invasion; prostate cancer recurrence;
D O I
10.1016/S0046-8177(98)90457-9
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
This study was performed to assess the relationship between the level and extent of prostatic capsular invasion (PCI) by cancer and the clinical and pathological features and prognosis of early-stage prostate cancer. We conducted a retrospective analysis of the clinical (age, stage, grade, prostate specific antigen [PSA] level) and pathological (tumor volume, stage, grade, surgical margins) features of 688 patients treated with radical prostatectomy to determine the pathological features and probability of recurrence associated with various levels of PCI. Radical prostatectomy specimens were serially sectioned and examined by whole-mount technique. Progression-free probabilities (PFP) after radical prostatectomy were determined by Kaplan-Meier and Cox proportional hazards regression analysis. Progression was defined as a rising serum PSA greater than or equal to 0.4 ng/mL or clinical evidence of recurrent cancer. Increasing clinical stage, Gleason grade in the biopsy specimen, and pretreatment serum PSA levels were each associated with increasing levels of PCI (P < .001). In the radical prostatectomy specimen, increasing levels of PCI were significantly associated with increasing tumor volume (P < .001), Gleason grade (P < .0001), seminal vesicle involvement (SVI, P < .001) and lymph node metastases (+LN, P < .001). None of 138 patients without capsular invasion had SVI or lymph node metastases (+LN), and all remained free of progression, even though some had large volume (up to 6.26 cm(3)) or poorly differentiated (Gleason sum up to 8) cancers. Invasion into the capsule (n = 271) was occasionally associated with SM (6%) or +LN (3%) and a significantly (log-rank test) lower PFP of 87% at 5 years. Focal and extensive extraprostatic extension (EPE) were associated with progressively increased risk of SVI and +LN and lower PFP (73% and 42%, respectively). In a multivariate analysis, the level of PCI was an independent prognostic factor (P < .001). There is a strong association between the level of invasion of cancer into or through the prostatic capsule and the volume, grade, pathological stage, and rate of recurrence after radical prostatectomy. Prostate cancer does not appear to metastasize in the absence of invasion into the capsule regardless of the volume or grade of the intracapsular tumor. Subclassification of patients according to the levels of PCI provides valuable prognostic information. Copyright (C) 1998 by W.B. Saunders Company.
引用
收藏
页码:856 / 862
页数:7
相关论文
共 50 条
  • [41] Is substaging necessary in patients with pathological stage T2 prostate cancer?
    Soydan, Hasan
    Ates, Ferhat
    Kucukodaci, Zafer
    Akyol, Ilker
    Karademir, Kenan
    Baykal, Kadir V.
    TURKISH JOURNAL OF UROLOGY, 2011, 37 (04): : 288 - 293
  • [42] Prognostic factors of organ confined prostate cancer with level 2 capsular invasion after radical prostatectomy
    Maru, N
    Utsunomiya, T
    Kattan, MW
    Scardino, PT
    Wheeler, TM
    LABORATORY INVESTIGATION, 1999, 79 (01) : 101A - 101A
  • [43] IGF-IEc Expression Is Associated with Advanced Clinical and Pathological Stage of Prostate Cancer
    Savvani, Argyro
    Petraki, Constantina
    Msaouel, Pavlos
    Diamanti, Evangelia
    Xoxakos, Ioannis
    Koutsilieris, Michael
    ANTICANCER RESEARCH, 2013, 33 (06) : 2441 - 2445
  • [44] Clinical significance of EPHX2 deregulation in prostate cancer
    Liu, Ming-Sheng
    Zhao, Hui
    Xu, Chen-Xiang
    Xie, Ping-Bo
    Wang, Wei
    Yang, Ying-Yu
    Lee, Wen-Hui
    Jin, Yang
    Zhou, Hong-Qing
    ASIAN JOURNAL OF ANDROLOGY, 2021, 23 (01) : 109 - +
  • [45] Clinical assessment and management of stage T3 prostate cancer
    Newling, DWW
    EUROPEAN UROLOGY, 1997, 32 : 55 - 59
  • [46] Prostate specific antigen detected prostate cancer (clinical stage T1c): An interim analysis
    Lerner, SE
    Seay, TM
    Blute, ML
    Bergstralh, EJ
    Barrett, D
    Zincke, H
    JOURNAL OF UROLOGY, 1996, 155 (03): : 821 - 826
  • [47] Tumor Size as a Critical Prognostic Factor in T1-2 Stage Esophageal Cancer
    Wu, Zilong
    Yu, Bentong
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2020, 2020
  • [48] Significance of Brain Imaging for Staging in Patients With Clinical Stage T1-2 N0 Non-Small-Cell Lung Cancer on Positron Emission Tomography/Computed Tomography
    Saito, Go
    Kono, Masato
    Koyanagi, Yu
    Miyashita, Koichi
    Tsutsumi, Akari
    Kobayashi, Takeshi
    Miki, Yoshihiro
    Hashimoto, Dai
    Nakamura, Toru
    Nozue, Masashi
    Nakamura, Hidenori
    CLINICAL LUNG CANCER, 2021, 22 (06) : 562 - 569
  • [49] Depth of invasion on pathological outcomes in clinical low-stage oral tongue cancer patients
    Masood, Maheer M.
    Farquhar, Douglas R.
    Vanleer, Jessica P.
    Patel, Samip N.
    Hackman, Trevor G.
    ORAL DISEASES, 2018, 24 (07) : 1198 - 1203
  • [50] PATHOLOGICAL RESULTS AND PROGNOSIS AFTER RADICAL CYSTECTOMY OF CLINICAL T1 STAGE BLADDER CANCER
    Kim, G. H.
    Han, K. S.
    Lee, Y. H.
    Ryu, H. S.
    Choi, Y. D.
    Yang, S. C.
    Hong, S. J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 126 - 126